Anti-GP39
Anti-GP39 Uses, Dosage, Side Effects, Food Interaction and all others data.
Anti-GP39 is under investigation in clinical trial NCT03605927 (CD40-L Blockade for Prevention of Acute Graft-versus-host Disease).
Trade Name | Anti-GP39 |
Generic | Toralizumab |
Toralizumab Other Names | Anti-CD 154 human-mouse monoclonal antibody, Anti-CD40L, Anti-GP39, Toralizumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Anti-GP39